Sipuleucel-T (sip-T) overall survival (OS) and clinical outcomes by baseline (BL) prostate-specific antigen (PSA) quartiles in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): PROCEED registry.
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: A. Oliver Sartor, Celestia S. Higano, Matthew R. Cooperberg, Nicholas J. Vogelzang, Shaker R. Dakhil, Christopher Michael Pieczonka, Jeff Vacirca, Raoul S Concepcion, Ronald F Tutrone, Luke T. Nordquist, Carl A Olsson, David F. Penson, Ian Schnadig, James L. Bailen, Bryan Mehlhaff, Nancy N. Chang, Nadeem Anwar Sheikh, Bruce Brown, Andrew J. Armstrong
Institutions: Tulane University, University of Washington, Fred Hutch Cancer Center, University of California, San Francisco, Comprehensive Cancer Centers of Nevada, Urology Associates, Chesapeake Urology Associates, Urology Cancer Center and GU Research Network, Columbia University Irving Medical Center, Vanderbilt University Medical Center, Compass Oncology, Oregon Urology Institute, Dendreon (United States), Duke University, Duke Cancer Institute
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2890554883